ICCT Stock Overview
A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
iCoreConnect Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.17 |
| 52 Week High | US$3.20 |
| 52 Week Low | US$0.15 |
| Beta | 0.68 |
| 11 Month Change | -35.56% |
| 3 Month Change | -68.22% |
| 1 Year Change | -86.40% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| ICCT | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -1.2% | 2.1% | 2.2% |
| 1Y | -86.4% | 8.2% | 31.6% |
Return vs Industry: ICCT underperformed the US Healthcare Services industry which returned 8.2% over the past year.
Return vs Market: ICCT underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| ICCT volatility | |
|---|---|
| ICCT Average Weekly Movement | 25.8% |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ICCT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ICCT's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 69 | Robert McDermott | www.icoreconnect.com |
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services.
iCoreConnect Inc. Fundamentals Summary
| ICCT fundamental statistics | |
|---|---|
| Market cap | US$1.74m |
| Earnings (TTM) | -US$30.79m |
| Revenue (TTM) | US$11.05m |
0.2x
P/S Ratio-0.1x
P/E RatioIs ICCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICCT income statement (TTM) | |
|---|---|
| Revenue | US$11.05m |
| Cost of Revenue | US$2.48m |
| Gross Profit | US$8.57m |
| Other Expenses | US$39.36m |
| Earnings | -US$30.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.00 |
| Gross Margin | 77.53% |
| Net Profit Margin | -278.64% |
| Debt/Equity Ratio | -344.8% |
How did ICCT perform over the long term?
See historical performance and comparison